NASACORT AQ SUMMARY
Nasacort® AQ
[na' za-cort]
(triamcinolone acetonide)
Nasal Spray
Triamcinolone acetonide, USP, the active ingredient in Nasacort® AQ Nasal Spray, is a corticosteroid.
Nasacort AQ Nasal Spray is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 6 years of age and older.
|
NASACORT AQ NEWS HIGHLIGHTS Media Articles Related to Nasacort AQ (Triamcinolone)
Morria Biopharmaceuticals Plc Announces Positive Clinical Results For MRX-4 In Its Phase II Clinical Study In Allergic Rhinitis Patients
Source: Arthritis / Rheumatology News From Medical News Today [2008.11.07]
Seasons Affect Hay Fever Sufferers Differently - MayoClinic.com
Source: Allergy News From Medical News Today [2008.10.30]
Children With Hay Fever More Likely To Experience Headaches, Facial Pain
Source: Headache / Migraine News From Medical News Today [2008.09.23]
Published Studies Related to Nasacort AQ (Triamcinolone)
Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study. [2008.10]
Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial. [2008.09.10]
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. [2008.09]
Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study. [2008.08]
A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. [2008.07]
Clinical Trials Related to Nasacort AQ (Triamcinolone)
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema [Completed]
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema [Active, not recruiting]
Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration [Completed]
Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) [Recruiting]
Intraocular Bevacizumab Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema [Recruiting]
|
NASACORT AQ PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 1 ratings/reviews, Nasacort AQ has an overall score of 10. The effectiveness score is 10 and the side effect score is 10. The scores are on ten point scale: 10 - best, 1 - worst.
| | Nasacort AQ review by 37 year old female patient | | | Rating |
| Overall rating: | |  |
| Effectiveness: | | Highly Effective |
| Side effects: | | No Side Effects | | |
Treatment Info |
| Condition / reason: | | sinusitis |
| Dosage & duration: | | 1 to 2 sprays per nostril per day (dosage frequency: 1x per day) for the period of regularly |
| Other conditions: | | allergies, headaches, sinus stuffiness, frequent colds |
| Other drugs taken: | | Sudafed otc, Semprex, Singulair | | |
Reported Results |
| Benefits: | | Nasacort AQ has proven to be extremely effective in controlling my nasal stuffiness and sinusitis related to allergies. Before use, it seemed my nose/sinuses were clogged on & off and made me much more susceptible to colds/flu--as much as 4 to 5 times per year & lasting 10 days to 2 weeks each round. I was miserable. Nasacort keeps my nasal passages open--it's a wonder!! |
| Side effects: | | No side effects noticed. |
| Comments: | | 1 to 2 sprays per nostril per day. I tried to limit to 1 spray per side per day & found is just as effective. This is on a regular, permanent basis to control allergies. |
|
|
|
Page last updated: 2008-11-07
|
